Premium
Hepatic encephalopathy in thioacetamide‐induced acute liver failure in rats: Characterization of an improved model and study of amino acid‐ergic neurotransmission
Author(s) -
Zimmermann Christof,
Ferenci Peter,
Pifl Christian,
Yurdaydin Cihan,
Ebner Josef,
Lassmann Hans,
Roth Erich,
Hörtnagl Heide
Publication year - 1989
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840090414
Subject(s) - hepatic encephalopathy , thioacetamide , gabaa receptor , medicine , glutamate receptor , endocrinology , neurotransmission , cirrhosis , biology , chemistry , receptor
An imbalance of excitatory and inhibitory amino acid‐ergic neurotransmission has been suggested to play a role in the pathogenesis of hepatic encephalopathy. For further evaluation of this hypothesis, several parameters of amino acid‐ergic neurotransmission were studied in rats with acute liver failure induced by the administration of 300 mg per kg thioacetamide by gavage on two consecutive days. By appropriate supportive care, hypoglycemia, renal failure and hypothermia were avoided. Rats were monitored clinically and neurologically. Hepatic encephalopathy evolved in four distinct, easily recognizable stages. Light and electron microscopic examination of brains of rats with hepatic encephalopathy revealed only a slight swelling of nuclei of neurons and astrocytes without signs of neuronal degeneration or brain edema. In rats with hepatic encephalopathy, the concentrations of GABA, glutamate and taurine were decreased in the cerebral cortex, the hippocampus and the stria‐tum, whereas those of aspartate and glycine were unchanged or increased. GABA A and benzodiazepine receptors were studied as parameters for the postsynaptic GABA A ‐benzodiazepine receptor complex, glutamic acid decarboxylase as parameter for presynaptic GABA‐ergic neurons and stimulation of benzodiazepine binding by GABA as a parameter for a GABA‐mediated postsynaptic event. None of these parameters was different in hepatic encephalopathy as compared to controls. Similarly, Ca ++ /Cl − ‐dependent and ‐independent glutamate receptors as parameters for glutamatergic neurons were unchanged in rats with hepatic encephalopathy. Thus, in rats with thioacetamide‐induced liver failure and hepatic encephalopathy, changes of the concentrations of neurotransmitter amino acids occur in the brain. Other neurochemical parameters, however, failed to identify alterations of GABA‐ergic or glutamatergic neurotransmission in hepatic encephalopathy.